Finance

Beta
Lists
7780:TPE
Daiken Biomedical Co Ltd
NT$17.80
+1.42%
(+0.25) 1D
Jun 3, 1:30:30 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 7780...
Open
NT$17.50
High
NT$17.90
Low
NT$17.50
Mkt. cap
14.42B
Avg. vol.
2.13M
Volume
2.47M
P/E ratio
39.35
52-wk high
NT$29.40
52-wk low
NT$16.00
EPS
NT$0.45
No. of employees
20
Open
NT$17.50
High
NT$17.90
Low
NT$17.50
Mkt. cap
14.42B
Avg. vol.
2.13M
Volume
2.47M
P/E ratio
39.35
52-wk high
NT$29.40
52-wk low
NT$16.00
EPS
NT$0.45
No. of employees
20
News stories
From sources across the web
Profile
Daiken Bio, officially known as Daiken Biomedical Co., Ltd., is a Taiwanese health supplement company established in June 2018. The company focuses on the research, development, production, and sales of nutritional products formulated with clinically tested ingredients. Wikipedia
About Daiken Biomedical Co Ltd
CEO-
Employees20
FoundedJun 20, 2018
Headquarters-
SectorPersonal care products
Previous reportsAll values in TWD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TWD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
454.88M
449.32M
656.11M
463.84M
Cost of goods sold
161.39M
161.39M
254.83M
185.10M
Cost of revenue
161.39M
161.39M
254.83M
185.10M
Research and development expenses
1.35M
2.32M
4.76M
1.90M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
247.48M
202.66M
272.70M
214.66M
Operating expense
248.83M
204.99M
277.47M
216.56M
Total operating expenses
410.22M
366.38M
532.29M
401.67M
Operating income
44.66M
82.95M
123.82M
62.18M
Other non operating income
-
-
113.00K
40.61M
EBT including unusual items
47.59M
86.03M
152.61M
140.41M
EBT excluding unusual items
47.59M
86.03M
152.61M
140.41M
Income tax expense
8.79M
16.61M
27.97M
36.05M
Effective tax rate
18.47%
19.30%
18.33%
25.68%
Other operating expenses
-
-
-
-
Net income
38.80M
69.42M
124.64M
104.36M
Net profit margin
8.53%
15.45%
19.00%
22.50%
Earnings per share
-
0.11
-
-
Interest and investment income
4.34M
2.73M
22.91M
38.45M
Interest expense
-5.00K
-108.00K
-468.00K
-827.00K
Net interest expenses
4.33M
2.62M
22.44M
37.62M
Depreciation and amortization charges
-
-
-
-
EBITDA
46.34M
84.85M
125.64M
63.99M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more